PAM
GILD icon

Palisade Asset Management’s Gilead Sciences GILD Stock Holding History

Palisade Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-417
Closed -$46.3K – 380
2025
Q3 		$46.3K Buy
+417
New +$47.4K ﹤0.01% 279
2024
Q2 		– Sell
-400
Closed -$29.3K – 267
2024
Q1 		$29.3K Buy
+400
New +$30.8K ﹤0.01% 301
2017
Q4 		– Sell
-2,800
Closed -$227K – 165
2017
Q3 		$227K Buy
+2,800
New +$214K 0.04% 132

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Palisade Asset Management's GILD Position: Q4 2025 in Review

Palisade Asset Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 417 shares — an estimated $46.3K sold.

Palisade Asset Management first reported a position in GILD in Q3 2017 and held it in 3 quarters. The position peaked at $227K in Q3 2017. 2,226 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • Palisade Asset Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • Palisade Asset Management sold 417 Gilead Sciences shares in Q4 2025, an estimated $46.3K.
  • Palisade Asset Management first reported a position in Gilead Sciences in Q3 2017 and held it in 3 quarters.
  • Palisade Asset Management's Gilead Sciences position peaked at $227K in Q3 2017.
  • 2,226 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Palisade Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.